FMS Post-Doc Symposium 2018 – Newcastle University (15th June 2018)

Dr Valeria Chichagova will be presenting at the inaugural Faculty of Medical Science (FMS) Post-Doc Symposium on Friday 15th June 2018.

Dr Chichagova will be talking about Retinitis Pigmentosa, one of the most common forms of inherited blindness affecting over 1 million people worldwide.

With no effective treatment available for Retinitis Pigmentosa and the mechanisms of the disease not fully understood, Dr Chichagova will present the results of a large collaborative effort undertaken under the leadership of Prof Majlinda Lako, with both Dr Chichagova and Mrs Buskin from Newcells Biotech amongst the main contributors. The presentation will include a discussion on how using patient-derived iPSCs, it was possible to obtain retinal organoids and retinal pigment epithelium cells to elucidate the molecular basis of the disease.

This is the first symposium of its kind for the faculty, organised by the newly-formed Post-Doctoral Committee. A keynote talk will be provided by Prof. Steve Wilson, Professor of Developmental Genetics at UCL, who will also present awards for the best paper, speaker and poster.

You might also be interested in…

Development of functioning in vitro lung assay for modelling Covid-19 infection

Newcells Biotech, experts in induced pluripotent stem cell (iPSC) differentiation and assay construction, have confirmed their human lung epithelium model as an effective platform for modelling SARS-CoV-2 infection and replication.  Their work alongside the Liverpool School of Tropical Medicine (LTSM) Centre for Drugs and Diagnostics will be crucial in helping

The Biosphere

Newcells Biotech scales up its operations in The Biosphere

Newcells Biotech, a pioneering life-sciences spin-out that applies Human induced Pluripotent Stem Cells (hiPSCs) to develop assays for drug development, have consolidated their two laboratory sites into 500m2 of laboratory and co-located office space in The Biosphere, which forms part of the Newcastle Helix cluster.    The purpose-built space in the city centre site

COVID-19 Vaccine

An Overview of Vaccine Development & Sub-Types

Vaccination can be regarded as one of biomedicines biggest triumphs. Since Edward Jenner pioneered the smallpox vaccine in 1798, subsequent morbidity and mortality rates have declined for a multitude of diseases, such as Diphtheria, Whooping Cough and Measles.1 However, despite the success of these global vaccination